Hyeong Rae Kim

Title: Hyeong Rae Kim: Innovator in Pyrimidine Derivatives

Introduction

Hyeong Rae Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications.

Latest Patents

Hyeong Rae Kim holds a patent for "2,4-pyrimidine derivatives and use thereof." This invention relates to novel 2,4-pyrimidine derivatives that are effective for systemic lupus erythematosus (SLE). The patent describes a composition for preventing and treating SLE, which includes these derivatives as an active ingredient. The invention also outlines a method for screening therapeutic agents for SLE, based on the mechanism of inhibiting the surface translocation of gp96.

Career Highlights

Throughout his career, Hyeong Rae Kim has worked with various organizations, including the Korea Research Institute of Chemical Technology. His research has focused on the development of innovative solutions for autoimmune diseases, particularly SLE.

Collaborations

Hyeong Rae Kim has collaborated with notable colleagues such as Sunghoon Kim and Jung Min Han. Their joint efforts have contributed to advancements in the understanding and treatment of autoimmune conditions.

Conclusion

Hyeong Rae Kim's work in developing pyrimidine derivatives showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of systemic lupus erythematosus and other autoimmune diseases.